Evidence map›Paper›PMID 36761922›Full record

ArticleHealth and technology2023

Artificial intelligence for non-invasive glycaemic-events detection via ECG in a paediatric population: study protocol.

Martina Andellini, Salman Haleem, Massimiliano Angelini, Matteo Ritrovato, Riccardo Schiaffini, Ernesto Iadanza, Leandro Pecchia

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Health and technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03936634 unknown statusnot on this map

An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA)

Typeobservational_patient_registrySponsorUniversity of CambridgeRan2016 to 2022Enrolled6,000ConditionsType 1 Diabetes Mellitus
NCT05278143 unknown statusnot on this map

Artificial Intelligence for Glycemic Events Detection Via Electrocardiogram in a Pediatric Population

TypeobservationalSponsorBambino Gesù Hospital and Research InstituteRan2021 to 2023Enrolled64Conditionstype1diabetes, Pediatrics
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Martina AndelliniSchool of Engineering, University of Warwick, CV4 7AL Coventry, UK.ORCID 0000-0002-2931-0753
Salman HaleemSchool of Engineering, University of Warwick, CV4 7AL Coventry, UK.
Massimiliano AngeliniHTA Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Matteo RitrovatoHTA Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Riccardo SchiaffiniDiabetes Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Ernesto IadanzaSchool of Engineering, University of Warwick, CV4 7AL Coventry, UK.
Leandro PecchiaSchool of Engineering, University of Warwick, CV4 7AL Coventry, UK.
Bambino Gesù Children's Hospital · ITUniversity of Warwick · GBUniversity of Siena · IT

Funding

Wellcome Trust
6 · The paper itself

Abstract

Purpose: Paediatric Type 1 Diabetes (T1D) patients are at greater risk for developing severe hypo and hyperglycaemic events due to poor glycaemic control. To reduce the risk of adverse events, patients need to achieve the best possible glycaemic management through frequent blood glucose monitoring with finger prick or Continuous Glucose Monitoring (CGM) systems. However, several non-invasive techniques have been proposed aiming at exploiting changes in physiological parameters based on glucose levels. The overall objective of this study is to validate an artificial intelligence (AI) based algorithm to detect glycaemic events using ECG signals collected through non-invasive device. Methods: This study will enrol T1D paediatric participants who already use CGM. Participants will wear an additional non-invasive wearable device for recording physiological data and respiratory rate. Glycaemic measurements driven through ECG variables are the main outcomes. Data collected will be used to design, develop and validate the personalised and generalized classifiers based on a deep learning (DL) AI algorithm, able to automatically detect hypoglycaemic events by using few ECG heartbeats recorded with wearable devices. Results: Data collection is expected to be completed approximately by June 2023. It is expected that sufficient data will be collected to develop and validate the AI algorithm. Conclusion: This is a validation study that will perform additional tests on a larger diabetes sample population to validate the previous pilot results that were based on four healthy adults, providing evidence on the reliability of the AI algorithm in detecting glycaemic events in paediatric diabetic patients in free-living conditions. Trial registration: ClinicalTrials.gov identifier: NCT03936634. Registered on 11 March 2022, retrospectively registered, https://www.clinicaltrials.gov/ct2/show/NCT05278143?titles=AI+for+Glycemic+Events+Detection+Via+ECG+in+a+Pediatric+Population&draw=2&rank=1. Supplementary information: The online version contains supplementary material available at 10.1007/s12553-022-00719-x.

Indexed as

Artificial Intelligence (AI)ECG signal processing, paediatric type 1 diabetes (T1D)Non-invasive glycaemia detection

Identifiers

PMID36761922
PMCPMC9899724
OpenAlexW4317787019

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.